CoChat

Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer

Sales, Manuela Vasconcelos Castro, Suemoto, Claudia K., Apolinario, Daniel, Serrao, ValeriaT., Andrade, Celi S., Conceição, David M., Amaro, Edson, de Melo, Brian Alvarez Ribeiro, Riechelmann, Rachel P. · 2019 · Clinical Colorectal Cancer
Cited by 26

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clcc.2018.09.002

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Silberfarb, 1983, Chemotherapy and cognitive defects in cancer patients, Annu Rev Med, 34, 35, 10.1146/annurev.me.34.020183.000343 · DOI · Paper page
  2. van Dam, 1998, Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy, J Natl Cancer Inst, 90, 210, 10.1093/jnci/90.3.210 · DOI · Paper page
  3. Schagen, 1999, Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma, Cancer, 85, 640, 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G · DOI · Paper page
  4. Brezden, 2000, Cognitive function in breast cancer patients receiving adjuvant chemotherapy, J Clin Oncol, 18, 2695, 10.1200/JCO.2000.18.14.2695 · DOI · Paper page
  5. Ahles, 2002, Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma, J Clin Oncol, 20, 485, 10.1200/JCO.2002.20.2.485 · DOI · Paper page
  6. Schagen, 2002, Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients, Ann Oncol, 13, 1387, 10.1093/annonc/mdf241 · DOI · Paper page
  7. Tchen, 2003, Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer, J Clin Oncol, 21, 4175, 10.1200/JCO.2003.01.119 · DOI · Paper page
  8. Castellon, 2004, Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen, J Clin Exp Neuropsychol, 26, 955, 10.1080/13803390490510905 · DOI · Paper page
  9. Wefel, 2004, The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial, Cancer, 100, 2292, 10.1002/cncr.20272 · DOI · Paper page
  10. Donovan, 2005, Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma, Cancer, 104, 2499, 10.1002/cncr.21482 · DOI
  11. Shilling, 2005, The effects of adjuvant chemotherapy on cognition in women with breast cancer—preliminary results of an observational longitudinal study, Breast, 14, 142, 10.1016/j.breast.2004.10.004 · DOI · Paper page
  12. Hurria, 2006, A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy, J Am Geriatr Soc, 54, 1119, 10.1111/j.1532-5415.2006.00789.x · DOI
  13. Bender, 2006, Cognitive impairment associated with adjuvant therapy in breast cancer, Psychooncology, 15, 422, 10.1002/pon.964 · DOI · Paper page
  14. Jenkins, 2006, A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer, Br J Cancer, 94, 828, 10.1038/sj.bjc.6603029 · DOI · Paper page
  15. Schagen, 2006, Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients, J Natl Cancer Inst, 98, 1742, 10.1093/jnci/djj470 · DOI · Paper page
  16. Scherwath, 2006, Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects, Ann Oncol, 17, 415, 10.1093/annonc/mdj108 · DOI
  17. Hermelink, 2007, Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study, Cancer, 109, 1905, 10.1002/cncr.22610 · DOI · Paper page
  18. Kreukels, 2008, Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer, Clin Breast Cancer, 8, 80, 10.3816/CBC.2008.n.006 · DOI
  19. Jim, 2009, Cognitive functioning in breast cancer survivors: a controlled comparison, Cancer, 115, 1776, 10.1002/cncr.24192 · DOI · Paper page
  20. Stewart, 2008, The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study, Psychooncology, 17, 122, 10.1002/pon.1210 · DOI · Paper page
  21. Quesnel, 2009, Cognitive impairments associated with breast cancer treatments: results from a longitudinal study, Breast Cancer Res Treat, 116, 113, 10.1007/s10549-008-0114-2 · DOI · Paper page
  22. Mehlsen, 2009, No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy, Psychooncology, 18, 248, 10.1002/pon.1398 · DOI
  23. Tager, 2010, The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study, Breast Cancer Res Treat, 123, 25, 10.1007/s10549-009-0606-8 · DOI
  24. Wefel, 2010, Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer, Cancer, 116, 3348, 10.1002/cncr.25098 · DOI · Paper page
  25. Ahles, 2010, Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve, J Clin Oncol, 28, 4434, 10.1200/JCO.2009.27.0827 · DOI · Paper page
  26. Cimprich, 2010, Prechemotherapy alterations in brain function in women with breast cancer, J Clin Exp Neuropsychol, 32, 324, 10.1080/13803390903032537 · DOI · Paper page
  27. Jansen, 2011, A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients, Support Care Cancer, 19, 1647
  28. Deprez, 2012, Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning, J Clin Oncol, 30, 274, 10.1200/JCO.2011.36.8571 · DOI · Paper page
  29. Ganz, 2013, Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance, J Natl Cancer Inst, 105, 791, 10.1093/jnci/djt073 · DOI · Paper page
  30. Anderson-Hanley, 2003, Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature, J Int Neuropsychol Soc, 9, 967, 10.1017/S1355617703970019 · DOI · Paper page
  31. Falleti, 2005, The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature, Brain Cogn, 59, 60, 10.1016/j.bandc.2005.05.001 · DOI · Paper page
  32. Jansen, 2005, A meta-analysis of studies of the effects of cancer chemotherapy on various domains of cognitive function, Cancer, 104, 2222, 10.1002/cncr.21469 · DOI · Paper page
  33. Stewart, 2006, A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer, Clin Neuropsychol, 20, 76, 10.1080/138540491005875 · DOI · Paper page
  34. Jim, 2012, Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy, J Clin Oncol, 30, 3578, 10.1200/JCO.2011.39.5640 · DOI · Paper page
  35. Saykin, 2003, Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological and neuroimaging perspectives, Semin Clin Neuropsychiatry, 8, 201
  36. Vardy, 2015, Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study, J Clin Oncol, 33, 4085, 10.1200/JCO.2015.63.0905 · DOI · Paper page
  37. Andreis, 2013, Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients: a pilot study, Support Care Cancer, 21, 583
  38. Laws, 2002, APOE-epsilon4 and APOE-491A polymorphisms in individuals with subjective memory loss, Mol Psych, 7, 768, 10.1038/sj.mp.4001083 · DOI
  39. Nathoo, 2003, Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E, Mol Pathol, 56, 132, 10.1136/mp.56.3.132 · DOI · Paper page
  40. Ahles, 2003, The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy, Psychooncology, 12, 612, 10.1002/pon.742 · DOI · Paper page
  41. Weintraub, 2009, The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery, Alzheimer Dis Assoc Disord, 23, 91, 10.1097/WAD.0b013e318191c7dd · DOI · Paper page
  42. Folstein, 1975, “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician, J Psychiatric Res, 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  43. Pfeffer, 1982, Measurement of functional activities in older adults in the community, J Gerontol, 37, 323, 10.1093/geronj/37.3.323 · DOI · Paper page
  44. Cannon, 2007, The PHQ-9 as a brief assessment of lifetime major depression, Psychol Assess, 19, 247, 10.1037/1040-3590.19.2.247 · DOI · Paper page
  45. Farias, 2008, The measurement of Everyday Cognition (ECog): scale development and psychometric properties, Neuropsychology, 22, 531, 10.1037/0894-4105.22.4.531 · DOI · Paper page
  46. Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
  47. Smith, 2004, Advances in functional and structural MR image analysis and implementation as FSL, Neuroimage, 23, S208, 10.1016/j.neuroimage.2004.07.051 · DOI · Paper page
  48. Smith, 2002, Fast robust automated brain extraction, Hum Brain Mapp, 17, 143, 10.1002/hbm.10062 · DOI · Paper page
  49. Andersson, 2016, An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging, Neuroimage, 125, 1063, 10.1016/j.neuroimage.2015.10.019 · DOI · Paper page
  50. Smith, 2006, Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data, Neuroimage, 31, 1487, 10.1016/j.neuroimage.2006.02.024 · DOI · Paper page
  51. Rueckert, 1999, Nonrigid registration using free-form deformations: application to breast MR images, IEEE Trans Med Imaging, 18, 712, 10.1109/42.796284 · DOI · Paper page
  52. Nelson, 2013, New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors, J Pain Symptom Manage, 46, 707, 10.1016/j.jpainsymman.2012.11.005 · DOI
  53. Cruzado, 2014, Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients, Support Care Cancer, 22, 1815
  54. Ahles, 2007, Candidate mechanisms for chemotherapy-induced cognitive changes, Nat Rev Cancer, 7, 192, 10.1038/nrc2073 · DOI · Paper page
  55. Meyers, 2008, How chemotherapy damages the central nervous system, J Biol, 7, 11
  56. Pinedo, 2007, Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin, J Clin Oncol, 25, 5320, 10.1200/JCO.2007.13.5954 · DOI
  57. Moris, 2007, Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine, J Neurol, 254, 534
  58. Hurria, 2006, Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study, J Am Geriatr Soc, 54, 925, 10.1111/j.1532-5415.2006.00732.x · DOI · Paper page
  59. Concha, 2013, A macroscopic view of microstructure: using diffusion-weighted images to infer damage, repair, and plasticity of white matter, Neuroscience, 276, 14, 10.1016/j.neuroscience.2013.09.004 · DOI
  60. Billiet, 2018, Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?, Brain Imaging Behav, 12, 64, 10.1007/s11682-016-9665-8 · DOI · Paper page
  61. Collins, 2009, Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment, Psychooncology, 18, 134, 10.1002/pon.1379 · DOI · Paper page
  62. Koppelmans, 2012, Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy, J Clin Oncol, 30, 1080, 10.1200/JCO.2011.37.0189 · DOI · Paper page
  63. Andre, 2017, Prospective pooled analysis of six phase II trials investigating duration of adjuvant (oxaliplatin-based therapy 3 vs 6 months) for patients with stage III colon cancer, J Clin Oncol, 35, LBA1

Metadata

Authors
Sales, M. V. C., Suemoto, C. K., Apolinario, D., Serrao, V., Andrade, C. S., Conceição, D. M., Amaro, E., de Melo, B. A. R., & Riechelmann, R. P.
Venue
Clinical Colorectal Cancer
Publisher
Elsevier BV
Published
2019-03
Volume
18
Issue
1
Pages
19-27
ISSN
1533-0028
Cited by
26
References
4
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/00895-8)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.